Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Okazuka K" with an ORCID

Kiyoshi Okazuka
No affiliation detected
1
Publication
6
Citations
View profile

Search results

1-25 of 38 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in Japan.
Iida S, Nakakoji M, Spanopoulos D, Okazuka K, Parulekar V, Ishida T
Future Oncol, 04 Nov 2022
Cited by: 1 article | PMID: 36331578
Add to export list
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry.
Sato K, Okazuka K, Ishida T, Sakamoto J, Kaneko S, Nashimoto J, Uto Y, Ogura M, Yoshiki Y, Abe Y, Maeda A, Hamazaki H, Tsukada N, Hiragohri Y, Suzuki K
Ann Hematol, 100(12):2989-2995, 25 Aug 2021
Cited by: 2 articles | PMID: 34430990
Add to export list
The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.
Okazuka K, Ishida T, Nashimoto J, Uto Y, Sato K, Miyazaki K, Ogura M, Yoshiki Y, Abe Y, Tsukada N, Suzuki K
Eur J Haematol, 104(2):110-115, 28 Nov 2019
Cited by: 6 articles | PMID: 31733155
Add to export list
[Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study].
Ogura M, Tsukada N, Yogo T, Nashimoto J, Uto Y, Sato K, Miyazaki K, Yoshiki Y, Abe Y, Okazuka K, Ishida T, Suzuki K
Rinsho Ketsueki, 61(11):1563-1569, 01 Jan 2020
Cited by: 0 articles | PMID: 33298647
Add to export list
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.
Suzuki K, Tsukada N, Nishimura N, Nagata Y, Okazuka K, Mishima Y, Yokoyama M, Nishiwaki K, Ishida T, Yano S, Terui Y, Suzuki K
Int J Hematol, 111(1):103-111, 30 Oct 2019
Cited by: 5 articles | PMID: 31673952
Add to export list
Red blood cell distribution width is a simple and novel biomarker for survival in light-chain amyloidosis.
Yogo T, Okazuka K, Nashimoto J, Uto Y, Sato K, Miyazaki K, Ogura M, Yoshiki Y, Abe Y, Tsukada N, Ishida T, Suzuki K
Int J Hematol, 110(4):431-437, 24 Jun 2019
Cited by: 4 articles | PMID: 31236823
Add to export list
[Elotuzumab treatment for a multiple myeloma patient relapsing after allogenic stem cell transplantation].
Sato K, Tsukada N, Nashimoto J, Uto Y, Miyazaki K, Ogura M, Yoshiki Y, Abe Y, Okazuka K, Ishida T, Suzuki K
Rinsho Ketsueki, 60(12):1635-1640, 01 Jan 2019
Cited by: 2 articles | PMID: 31902813
Add to export list
[Efficacy of plerixafor in autologous peripheral blood stem cell collection].
Yogo T, Tsukada N, Nashimoto J, Uto Y, Sato K, Miyazaki K, Ogura M, Yoshiki Y, Abe Y, Okazuka K, Ishida T, Suzuki K
Rinsho Ketsueki, 60(3):165-170, 01 Jan 2019
Cited by: 1 article | PMID: 31068511
Add to export list
[Clinical characteristics of young multiple myeloma patients: a single-center analysis of 30 patients].
Yoshiki Y, Tsukada N, Nashimoto J, Yogo T, Uto Y, Sato K, Miyazaki K, Ogura M, Abe Y, Okazuka K, Ishida T, Suzuki K
Rinsho Ketsueki, 60(10):1411-1417, 01 Jan 2019
Cited by: 0 articles | PMID: 31695000
Add to export list
Proteasome inhibitors for multiple myeloma.
Okazuka K, Ishida T
Jpn J Clin Oncol, 48(9):785-793, 01 Sep 2018
Cited by: 31 articles | PMID: 30102324
Add to export list Review
[A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].
Sato M, Watanabe S, Aoki N, Asakawa K, Moriyama H, Oshima Y, Koya T, Okazuka K, Kikuchi T
Gan To Kagaku Ryoho, 45(5):851-854, 01 May 2018
Cited by: 2 articles | PMID: 30026450
Add to export list
[Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients].
Okazuka K, Ishida T, Sato K, Miyazaki K, Yoshiki Y, Abe Y, Tsukada N, Suzuki K
Rinsho Ketsueki, 59(6):698-700, 01 Jan 2018
Cited by: 0 articles | PMID: 29973446
Add to export list
Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia.
Ito S, Fujiwara SI, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
Ann Hematol, 96(5):719-724, 01 Feb 2017
Cited by: 7 articles | PMID: 28144729
Add to export list Review
CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.
Fujiwara SI, Muroi K, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Ozawa K
Hematology, 22(6):347-353, 18 Jan 2017
Cited by: 10 articles | PMID: 28097942
Add to export list
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement.
Umino K, Fujiwara SI, Sato K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Yamamoto C, Hatano K, Okazuka K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
Acta Haematol, 137(2):93-99, 25 Jan 2017
Cited by: 4 articles | PMID: 28118621
Add to export list
[IgE-κ type multiple myeloma achieving complete response with novel agents].
Takei T, Ishida T, Ikeda M, Shingaki S, Miyazaki K, Yoshiki Y, Abe Y, Okazuka K, Iki S, Tsukada N, Suzuki K
Rinsho Ketsueki, 58(11):2232-2237, 01 Jan 2017
Cited by: 1 article | PMID: 29212974
Add to export list Review
Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia.
Yamamoto C, Ito S, Mashima K, Umino K, Minakata D, Yamasaki R, Kawasaki Y, Sugimoto M, Nakano H, Ashizawa M, Okazuka K, Hatano K, Sato K, Oh I, Fujiwara S, Ohmine K, Suzuki T, Muroi K, Kanda Y
Leuk Lymphoma, 57(11):2541-2547, 25 Feb 2016
Cited by: 1 article | PMID: 26917050
Add to export list
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
Sugimoto M, Ito S, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Ashizawa M, Yamamoto C, Fujiwara S, Okazuka K, Hatano K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kako S, Kanda Y
Ann Hematol, 95(9):1513-1519, 01 Jul 2016
Cited by: 11 articles | PMID: 27365141
Add to export list
Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
Suzuki T, Kobayashi H, Kawasaki Y, Okazuka K, Hatano K, Fujiwara S, Oh I, Ohmine K, Kanda Y
Int J Hematol, 104(4):446-453, 23 Jun 2016
Cited by: 11 articles | PMID: 27338268
Add to export list
Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
Umino K, Fujiwara SI, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
Leuk Lymphoma, 58(2):316-323, 07 Jun 2016
Cited by: 6 articles | PMID: 27267694
Add to export list
A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis.
Minakata D, Fujiwara S, Ito S, Mashima K, Umino K, Nakano H, Kawasaki Y, Sugimoto M, Yamasaki R, Yamamoto C, Ashizawa M, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
Leuk Res, 42:82-87, 02 Jan 2016
Cited by: 8 articles | PMID: 26790727
Add to export list
The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemia.
Nakano H, Fujiwara SI, Ito S, Mashima K, Umino K, Minakata D, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y
Hematol Oncol, 35(3):357-364, 07 Dec 2015
Cited by: 0 articles | PMID: 26639319
Add to export list
CD56 expression in normal immature granulocytes after allogeneic hematopoietic stem cell transplantation.
Muroi K, Fujiwara S, Tatara R, Sugimoto M, Yamamoto C, Uehara E, Meguro A, Hatano K, Okazuka K, Oh I, Ohmine K, Suzuki T, Mori M, Nagai T, Ozawa K
J Clin Exp Hematop, 53(3):247-250, 01 Jan 2013
Cited by: 3 articles | PMID: 24369228
Add to export list
Successful treatment of severe newly diagnosed immune thrombocytopenia involving an alveolar hemorrhage with combination therapy consisting of romiplostim, rituximab and vincristine.
Okazuka K, Masuko M, Matsuo Y, Miyakoshi S, Tanaka T, Kozakai T, Kobayashi H, Fuse K, Shibasaki Y, Moriyama M, Takizawa J, Fuse I, Toba K, Furukawa T
Intern Med, 52(11):1239-1242, 01 Jan 2013
Cited by: 4 articles | PMID: 23728563
Add to export list
Corrigendum to "Long-term Regulation of Genetically Modified Primary Hematopoietic Cells in Dogs".
Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Torok-Storb B, Kiem HP, Blau CA
Mol Ther, 19(11):2102, 01 Nov 2011
Cited by: 0 articles | PMID: 28160652 | PMCID: PMC3222532
Add to export list Free full text in Europe PMC

1-25 of 38 results

1 2

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Okazuka K" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Okazuka K" with an ORCID